https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1516725/full
Frontiers | Reframing risks in rare diseases: economics of networks, spillovers, and scale
Rare diseases affect over three hundred million individuals globally. Investment in research and development remains incommensurate with the challenges rare ...
economics of networksrare diseases